Overseas Company Profile
✉ Email this page to a colleague
What is the competitive landscape for OVERSEAS, and what generic and branded alternatives to OVERSEAS drugs are available?
OVERSEAS has one approved drug.
Summary for Overseas
| US Patents: | 0 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Overseas
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overseas | LEVETIRACETAM | levetiracetam | TABLET, EXTENDED RELEASE;ORAL | 212688-002 | May 5, 2023 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Overseas | LEVETIRACETAM | levetiracetam | TABLET, EXTENDED RELEASE;ORAL | 212688-001 | Jun 11, 2020 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
